Abstract
Immune responses in Marek’s disease (MD) are complicated by antagonism between immunity on the one hand and immunosuppression on the other. Lymphocytes are responsible for mounting immune responses, some of which may contribute to protection while others may be involved in the pathology of the disease, and it is the same cell type that is the primary target for infection with Marek’s disease virus (MDV). Infection may be lytic, resulting in cell death, or it may lead to malignant transformation; both types of infection appear to be associated with immunosuppression. It is assumed that an efficient host immune response limits the extent and spread of virus replication, and also contributes to the regression and rejection of tumour cells. At the same time virus-induced immunosuppression will be acting to limit the effectiveness of these responses. The outcome of infection therefore depends upon a balance between the immune responses provoked by the virus and tumour antigens and the immunosuppression caused by the replication of the virus in the lymphoid organs. Nevertheless, the importance of the immune system in ensuring that this internecine struggle results in a satisfactory outcome from the chicken’s point of view has been amply demonstrated by the success of a variety of live virus vaccines against MD (1).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Powell PC: Immunity to Marek’s disease. In: Rose ME, Payne LN, Freeman BM (eds) Avian Immunology. British Poultry Science, Edinburgh, 1981, pp 263–283.
Payne LN, Frazier JA, Powell PC: Pathogenesis of Marek’s disease. Int Rev Exp Pathol (16):59–154, 1976.
Schat KA, Calnek BW: Characterization of an apparently non- oncogenic Marek’s disease virus. J Natl Cancer Inst (60):1075–1082, 1978.
Payne IN: Biology of Marek’s disease virus and the herpesvirus of turkeys. In: Roizman B (ed) The Herpesviruses. Plenum Press, New York, 1982, Vold, pp 347–431.
Cole RK: Studies on genetic resistance to Marek’s disease. Avian Dis (12):9–28, 1968.
Cole RK: The genetics of resistance to Marek’s disease. In: Biggs PM, de Thé G, Payne LN (eds) Oncogenesis and Herpesviruses, IARC Scientific Publications No 2, International Agency for Research on Cancer, Lyon, 1973, pp 123–128.
Cole RK, Hutt FB: Selection and heterosis in Cornell white leghorns: a review, with special consideration of interstrain hybrids. Anim Breed Abstr (41):103–118, 1973.
Waters NF: Mortality from lymphomatosis and other causes among inbred lines of white leghorns. Poult Sci (30):531–545, 1951.
Fabricant J, Calnek BW, Schat KA, Murthy KK: Marek’s disease virus-induced tumor transplants: development and rejection in various genetic strains of chickens. Avian Dis (22):646–658, 1978.
Chubb RC, Churchill AE: Precipitating antibodies associated with Marek’s disease. Vet Rec (83):4–7, 1968.
Calnek BW: Effects of passive antibody on early pathogenesis of Marek’s disease. Infect Immun (6):193–205, 1972.
Ball RF, Hill JF, Lyman J, Wyatt A: The resistance to Marek’s disease of chicks from immunized breeders. Poult Sci (50):1084–1090, 1971.
Churchill AE, Chubb RC, Baxendale W: The attenuation, with loss of oncogenicity, of the herpes-type virus of Marek’s disease (strain HPRS-16) on passage in cell culture. J Gen Virol (4): 557–564, 1969.
Calnek BW, Carlisle JC, Fabricant J, Murthy KK, Schat KA: Comparative pathogenesis studies with oncogenic and nononcogenic Marek’s disease viruses and turkey herpesvirus. Am J Vet Res (40): 541–548, 1979.
Witter RL, Sharma JM, Offenbecker L: Turkey herpesvirus infection in chickens: induction of lymphoproliferative lesions and characterization of vaccinal immunity against Marek’s disease. Avian Dis (20):676–692, 1976.
Witter RL, Sharma JM, Solomon JJ, Champion LR: An age-related resistance of chickens to Marek’s disease: some preliminary observations. Avian Pathol (2):43–54, 1973.
Calnek BW: Influence of age at exposure on the pathogenesis of Marek’s disease. J Natl Cancer Inst (51):929–939, 1973.
Powell PC, Payne LN, Frazier JA, Rennie M: T lymphoblastoid cell lines from Marek’s disease lymphomas. Nature (251):79–80, 1974.
Witter RL, Stephens EA, Sharma JM, Nazerian K: Demonstration of a tumor associated surface antigen in Marek’s disease J Imnunol (115):177–183, 1975.
Schat KA, Calnek BW: Demonstration of Marek’s disease tumor- associated surface antigen in chickens infected with nononcogenic Marek’s disease virus and herpesvirus of turkeys. J Natl Cancer Inst (61):855–857, 1978.
Powell PC, Rennie M: Marek’s disease tumour-associated surface antigen (MATSA) induced in inoculated chickens by vaccines against Marek’s disease. In: Biggs PM (ed) Resistance and Immunity to Marek’s Disease. CEC Publication EUR 6470, Luxembourg, 1980, pp 341–351.
Ross LJN: Characterization of an antigen associated with Marek’s disease lymphoblastoid cell line MSB-1. J Gen Virol (60):375–380, 1982.
Powell PC, Hartley KJ, Mustill BM, Rennie M: The occurrence of chicken foetal antigen after infection with Marek’s disease virus in three strains of chicken. Oncodev Biol Med (4):261–271, 1983.
Schat KA, Chen C-LH, Shek WR, Calnek BW: Surface antigens on Marek’s disease lymphoblastoid cell lines. J Natl Cancer Inst (69): 715–720, 1982.
Purchase HG, Burgoyne GH: Imnunofluorescence in the study of Marek’s disease: detection of antibody. Am J Vet Res (31):117–123, 1970.
Calnek BW: Antibody development in chickens exposed to Marek’s disease virus. In: Biggs PM, de Thé G, Payne LN (eds) Oncogenesis and Herpesviruses, IARC Scientific Publications No 2, International Agency for Research in Cancer, Lyon, 1972, pp 129–136.
Sharma JM, Stone HA: Genetic resistance to Marek’s disease. Delineation of the response of genetically resistant chickens to Marek’s disease virus infection. Avian Dis (16):894–906, 1972.
Eidson CS, Schmittle SC: Studies on acute Marek’s disease. XII. Detection of antibodies with a tannic acid indirect hemagglutination test. Avian Dis (13):774–782, 1969.
Marquardt WW, Newman JA: A modified direct complement-fixation test for detection of Marek’s disease antibodies in chick serum. Avian Dis (16):986–996, 1972.
Srivastava RN, Kaushik AK, Prasad S: Enzyme-linked inmunosorbent assay of serum antibodies to Marek’s disease virus in vaccinated chickens. Acta Virol (26):302, 1982.
Higgins DA, Calnek BW: Fowl immunoglobulins: quantitation and antibody activity during Marek’s disease in genetically resistant and susceptible birds. Infect Immun (11):33–41, 1975.
Stephens EA, Witter RL, Nazerian K, Sharma JM: Development and characterization of a Marek’s disease transplantable tumor in inbred, line 72 chickens homozygous at the major (B) histocompatibility locus. Avian Dis (24):358–374, 1980.
Sugimoto C, Kodama H, Mikami T: Anti-tumor immunity against Marek’s disease-derived lymphoblastoid cell line (MSB-1). Jpn J Vet Res (26):57–67, 1978.
Kitamoto N, Ikuta K, Kato S, Yamaguchi S: Cell-mediated cytotoxicity of lymphocytes from chickens inoculated with herpesvirus of turkey against Marek’s disease lymphoma cell line (MSB-1). Biken J (22):11–20, 1979.
Calnek BW, Fabricant J, Schat KA, Murthy KK: Rejection of a transplantable Marek’s disease lymphoma in normal versus immunologically deficient chickens. J Natl Cancer Inst (60):623–630, 1978.
Byerly JL, Dawe DL: Delayed hypersensitivity reactions in Marek’s disease virus infected chickens. An J Vet Res (33):2267–2273, 1972.
Fauser IS, Purchase HG, Long PA, Velicer LF, Mailman H, Fauser HT, Winegar GO: Delayed hypersensitivity and leucocyte migration inhibition in chickens with BCG or Marek’s disease infection. Avian Pathol (2):55–61, 1973.
Schat KA, Calnek BW: In vitro inactivation of cell-free Marek’s disease herpesvirus by immune peripheral blood lymphocytes. Avian Dis (22):693–697, 1978.
Lee LE: Macrophage restriction of Marek’s disease virus replication and lymphoma cell proliferation. J Immunol (123):1088–1091, 1979.
Ross LJN: Antiviral T cell-mediated immunity in Marek’s disease. Nature (268):644–646, 1977.
Kodama H, Sugimoto C, Image F, Mikami T: Anti-viral immunity against Marek’s disease virus infected chicken kidney cells. Avian Pathol (8):33–44, 1979.
Ross LIN: Mechanism of protection conferred by HVT. In: Biggs PM (ed) Resistance and Immunity to Marek’s Disease. CEC Publication EUR 6470, Luxembourg, 1980, pp 289–300.
Powell PC: Studies on Marek’s disease lymphoma-derived cell lines. Bibl Haemat (43):348–350, 1976.
Sharma JM, Coulson BD: Cell-mediated cytotoxic repsonse to cells bearing Marek’s disease tumor-associated surface antigen in chickens infected with Marek’s disease virus. J Natl Cancer Inst (58):1647–1651, 1977.
Sharma JM: Immunopathology of Marek’s disease. In: Gershwin ME, Cooper EL (eds) Animal Models of Comparative and Developmental Aspects of Immunity and Disease. Pergamon Press, Oxford, 1978, pp. 132–142.
Confer AN, Adldinger HK: Cell-mediated immunity in Marek’s disease: cytotoxic responses in resistant and susceptible chickens and relation to disease. Am J Vet Res (41):307–312, 1980.
Sharma JM, Witter RL, Coulson BD: Development of cell-mediated immunity to Marek’s disease tumor cells in chicks inoculated with Marek’s disease vaccines. J Natl Cancer Inst (61):1273–1280, 1978.
Dambrine G, Coudert F, Cauchy L: Cell-mediated cytotoxicity in chickens infected with Marek’s disease virus and the hepresvirus of turkeys. In: Biggs PM (ed) Resistance and Immunity to Marek’s disease CEC Publication EUR 6470, Luxembourg, 1980, pp 320–337.
Murthy KK, Calnek BW: Pathogenesis of Marek’s disease: early appearance of Marek’s disease tumor-associated surface antigen in infected chickens. J Natl Cancer Inst (61):849–854, 1978.
Sharma JM: Cell-mediated immunity to tumor antigen in Marek’s disease: susceptibility of effector cells to antithymocyte serum and enhancement of cytotoxic activity by Vibrio cholerae neuraminidase. Infect Immun (18):46–51, 1977.
Schat KA, Murthy KK: In vitro cytotoxicity against Marek’s disease lymphoblastoid cell lines after enzymic removal of Mare-k’s disease tumor associated surface antigen. J Virol (34): 130–135, 1980.
Schat KA, Shek WR, Calnek BW, Abplanalp H: Syngeneic and allogeneic cell-mediated cytotoxicity against Marek’s disease lymphoblastoid tumor cell lines. Int J Cancer (29):187–194, 1982.
Powell PC, Mustill BM, Rennie M: The role of histocompatibility antigens in cell-mediated cytotoxicity against Mare-k’s disease lymphoblastoid cell lines. Avian Pathol (12):461–468, 1983.
Confer AW, Adldinger HK, Buening G1: Cell-mediated immunity in Marek’s disease: correlation of disease-related variables with immune responses in age-resistant chickens. Am J Vet Res (41): 313–318, 1980.
Payne LN, Powell PC, Rennie M, Ross LJN: Vaccination of bursectomised chickens with inactivated Marek’s disease virus-specific antigens. Avian Pathol (7):427–432, 1978.
Powell R: Protection against the JMV Marek’s disease derived transplantable tumour by Marek’s disease virus-specific antigens. Avian Pathol (7):305–309, 1978.
Higgins DA, Calnek BW: Sane effects of silica treatment on Marek’s disease. Infect Immun (13):1054–1060, 1976.
Haffer K, Sevoian M, Wilder M: The role of the macrophage in Marek’s disease: in vitro and in vivo studies. Int J Cancer (23):648–656, 1979.
Lee LF, Sharma JM, Nazerian K, Witter RL: Suppression of mitogeninduced proliferation of normal spleen cells by macrophages from chickens inoculated with Marek’s disease virus. J Immunol (120): 1554–1615, 1978.
Kodama H, Mikami T, Inoue M, Izawa H: Inhibitory effects of macrophages against Marek’s disease virus plaque formation in chicken kidney cell cultures. J Natl Cancer Inst (63):1267–1271, 1979.
Sharma JM: In vitro suppression of T-cell mitogenic response and tumor cell proliferation by spleen macrophages from normal chickens. Infect Immun (28):914–922, 1980.
Kaleta EF, Bankowski RA: Viral interference of types 1 and 2 plaque-producing agents derived from Cal-1 strain of Marek’s disease herpesvirus and turkey herpesvirus. J Natl Cancer Inst (48):1303–1310, 1972.
Kaleta EF, Bankowski RA: Production of interferon by the Cal-1 and turkey herpesvirus strains associated with Marek’s disease. Am J Vet Res (33):567–571, 1972.
Hong CC, Sevoian M: Interferon production and host resistance to type II avian (Marek’s) leukosis virus (JM strain). Appl Microbiol (22):818–820, 1971.
Vengris VE, Mare CJ: Protection of chickens against Marek’s disease virus JM -V strain with statolon and exogenous interferon. Avian Dis (17):758–767, 1973.
Sharma JM, Coulson BD: Natural immunity against Marek’s disease tumour cells: cytotoxicity of spleen cells from specific pathogen free chickens against MSB-1 target cells. In: Biggs PM (ed) Resistance and Immunity to Marek’s Disease. CEC Publication EUR 6470, Luxembourg, 1980, pp 223–229.
Lam KM, Linna TJ: Transfer of natural resistance to Marek’s disease (JMV) with non-immune spleen cells. I. Studies of cell population transferring resistance. Int J Cancer (24): 662–667, 1979.
Sharma JM: Natural killer cell activity in chickens exposed to Marek’s disease virus: inhibition of activity in susceptible chickens and enhancement of activity in resistant and vaccinated chickens. Avian Dis (25):882–895, 1981.
Lee LF, Powell PC, Rennie M, Ross LJN, Payne LN: Nature of genetic resistance to Marek’s disease in chickens. J Natl Cancer Inst (66):789–796, 1981.
Gallatin WM, Longenecker BM: Expression of genetic resistance to an oncogenic herpesvirus at the target cell level. Nature (280): 587–589, 1979.
Powell PC, Lee LF, Mustill BM, Rennie M: The mechanism of genetic resistance to Marek’s disease in chickens. Int J Cancer (29):169–174, 1982.
Sharma JM: Resistance to Marek’s disease in immunologically deficient chickens. Nature (247):117–118, 1974.
Powell PC, Hartley KJ, Mustill BM, Rennie M: Studies on the role of macrophages in Marek’s disease of the chicken. J Reticuloend Soc (34):289–297, 1983.
Sharma JM, Witter RL: The effect of B-cell inmunosuppression on age-related resistance of chickens to Marek’s disease. Cancer Res (35):711–717, 1975.
Smith Ma, Calnek BW: Effect of virus pathogenicity on antibody production in Marek’s disease. Avian Dis (17):727–736, 1973.
Shieh HK, Sevoian M: The influence of humoral and cellular immune system on chickens with Marek’s disease. J Chin Vet Sci (4):3–13, 1978.
Sharma JM, Nazerian K, Witter RL: Reduced incidence of Marek’s disease gross lymphomas in T-cell depleted chickens. J Natl Cancer Inst (58):689–692, 1977.
Fabricant J, Ianconescu M, Calnek BW: Comparative effects of host and viral factors on Party pathogenesis of Marek’s disease. Infect Immun (16):136–144, 1977.
Murthy KK, Calnek BW: Marek’s disease tumor-associated surface antigen (MATSA) in resistant versus susceptible chickens. Avian Dis (23):831–837, 1979.
Payne LN, Rennie M: Pathogenesis of Marek’s disease in chicks with and without maternal antibody. J Natl Cancer Inst (51):1559–1573, 1973.
Burgoyne GH, Witter RL: Effect of passively transferred inrmunoglobulins on Marek’s disease. Avian Dis (17):824–837, 1973.
Frazier JA: Ultrastructure of lymphoid tissue from chicks infected with Marek’s disease virus. J Natl Cancer Inst (52):829–837, 1974.
Biggs PM, Milne BS: Use of the embryonating egg in studies on Marek’s disease. Am J Vet Res (32):1795–1809, 1971.
Churchill AE: Herpes-type virus isolated in cell culture from tumors of chickens with Marek’s disease. 1. Studies in cell culture. J Natl Cancer Inst (41):939–950, 1968.
Witter RL, Solomon JJ, Champion LR, Nazerian K: Long-term studies of Marek’s disease infection in individual chickens. Avian Dis (15):346–365, 1971.
Powell PC, Lawn AM, Payne LN, Rennie M, Ross LJN: The effect of virus dose on the development of Marek’s disease in two strains of chickens. Avian Pathol (9):567–574, 1980.
Powell FC, Rowell JG: Dissociation of antiviral and antitumor immunity in resistance to Marek’s disease. J Nati Cancer Inst (59):919–924, 1977.
Hirai K, Ikuta K, Kitamoto M, Kato S: Latency of herpesvirus of turkeys and Marek’s disease virus genome in a chicken T-lymphoblastoid cell line. J Gen Virol (53):133–143, 1981.
Purchase HG, Sharpe JM: Amelioration of Marek’s disease and absence of vaccine protection in immunologically deficient chicks. Nature (248):419–421, 1974.
Billow V von: Cross protection between JMV Marek’s disease-derived tumour transplant, Marek’s disease and turkey herpesviruses. Avian Pathol (6):353–366, 1977.
Schat KA, Calnek BW: Protection against Marek’s disease derived tumor transplants by the non-oncogenic SB-1 strain of Marek’s disease virus. Infect Immun (22):225–232, 1978.
Powell PC, Rennie M: Failure of attenuated Marek’s disease virus and herpesvirus of turkey antigens to protect against the JMV Marek’s disease derived transplantable tumour. Avian Pathol (9): 193–200, 1980.
Elmubarak AK, Sharma JM, Witter RL, Sanger VL: Marek’s disease in turkeys: lack of protection by vaccination. Am J Vet Res (43):740–742, 1982.
Powell PC, Rennie M: The expression of Marek’s disease tumour-associated surface antigen in various avian species. Avian Pathol (13):345–349, 1984.
Nazerian K, Witter RL: Immunization against Marek’s disease transplantable cell lines. Avian Dis (28):160–167, 1984.
Kaaden OR, Dietzschold B, Ueberschar S: Vaccination against Marek’s disease: Immunizing effect of purified turkey herpesvirus and cellular membranes from infected cells. Med Microbiol Inmunol (Berl) (159):261–269, 1974.
Lesnik F, Ross LJN: Immunization against Marek’s disease using Marek’s disease virus-specific antigens free from infectious virus. Int J Cancer (16):153–163, 1975.
Powell PC: Immunity to Marek’s disease induced by glutaraldehydetreated cells of Marek’s disease lymphoblastoid cell lines. Nature (257):684–685, 1975.
Murthy KK, Calnek BW: Pathogenesis of Marek’s disease: effect of immunization with inactivated viral and tumor-associated antigen. Infect Immun (26):547–553, 1979.
Gupta SK, Kharole MU, Kalva DS: Role of thymus-dependent immune system in HVT protection against Marek’s disease. Avian Dis (26): 134–139, 1982.
Else RW: Vaccinal impunity to Marek’s disease in bursectomised chickens. Vet Rec (95):182–187, 1974.
Rennie M, Powell PC, Mustill BM: The effect of bursectomy on vaccination against Marek’s disease with the herpesvirus of turkeys. Avian Pathol (9):557–566, 1980.
Payne LN, Rennie MC, Powell PC, Rowell JG: Transient effect of cyclophosphamide on vaccinal immunity to Marek’s disease. Avian Pathol (7):295–304, 1978.
Powell PC, Rennie M, Ross LJN, Mustill BM: The effect of bursectany on the adoptive transfer of resistance to Marek’s disease. Int J Cancer (26):681–687, 1980.
Sharma JM, Witter RL,Purchase HG: Absence of age resistance in neonatally thymectomised chickens as evidence for cell-mediated immune surveillance in Marek’s disease. Nature (253):477–479, 1975.
Sharma JM, Witter RL, Burmester BR: Pathogenesis of Marek’s disease in old chickens: lesion regression as the basis for age-related resistance. Infect Immun (8):715–724, 1973.
Lee LF, Sharma JM, Nazerian K, Witter RL: Suppression and enhancement of mitogen response in chickens infected with Marek’s disease virus and the herpesvirus of turkeys. Infect Immun (21): 474–479, 1978.
Schat KA, Schultz RD, Calnek BW: Marek’s disease: effect of virus pathogenicity and genetic susceptibility on responses of peripheral blood lymphocytes to concanavalin A. In: Bentvelzen P, Hilgers J, Yohn DS (eds) Advances in Comparative Leukemia Research 1977. Elsevier/North Holland Biomedical Press, Amsterdam, 1978, pp 183–186.
Powell PC: In vitro stimulation of blood lymphocytes by phytohaenagglutinin during the development of Marek’s diseagP. Avian Pathol (9):471–475, 1980.
Purchase HG, Chubb RC, Biggs PM: Effect of lymphoid leukosis and Marek’s disease on the immunological responsiveness of the chicken. J Natl Cancer Inst (40):583–592, 1968.
Evans DL, Patterson LT: Correlation of immunological responsiveness with lymphocyte changes in chickens infected with Marek’s disease. Infect Immun (4):567–574, 1971.
Burg RW, Feldbush T, Morris CA, Maag TA: Depression of thymus-and bursa-dependent immune systems of chicks with Marek’s disease. Avian Dis (15):662–671, 1971.
Payne LN: Immunosuppressive effects of avian oncogenic viruses. Proc Roy Soc Med (63):16–19, 1970.
Schierman LW, Theis GA, McBride RA: Preservation of a T cell-mediated immune response in Marek’s disease virus-infected chickens by vaccination with a related virus. J Immunol (116): 1497–1499, 1976.
Biggs PM, Long PL, Kenzy SG, Rootes DG: Relationship between Marek’s disease and coccidiosis. II. The effect of Marek’s disease on the susceptibility of chickens to coccidial infection. Vet Rec (83):284–289, 1968.
Calnek BW, Higgins DA, Fabricant J: Rous sarcoma regression in chickens resistant or susceptible to Marek’s disease. Avian Dis (19):473–482, 1975.
Weinberg MA, Beiss B, Israel E: Virus-mediated abrogation of chicken lymphocyte responsiveness to mitogen stimulus. Avian Dis (24):580–590, 1980.
Theis GA: Effects of lymphocytes from Marek’s disease infected chickens on mitogenic responses of syngeneic normal chicken spleen cells. J Immunol (118):887–894, 1977.
Theis GA: Immune reactivity in Marek’s disease during viral oncogenesis and protective vaccination. In: Ames DB, Schwartz RS, Janicki BW (eds) Immune Mechanisms and Disease. Academic Press, New York, 1979, pp 323–338.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Powell, P.C. (1985). Immunity. In: Payne, L.N. (eds) Marek’s Disease. Developments in Veterinary Virology, vol 1. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2613-7_7
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2613-7_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9635-5
Online ISBN: 978-1-4613-2613-7
eBook Packages: Springer Book Archive